—] Shares Virobay, Inc. Common Stock PURCHASE AGREEMENTPurchase Agreement • October 6th, 2014 • Virobay Inc • Pharmaceutical preparations • New York
This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.
INDEMNITY AGREEMENTIndemnity Agreement • September 10th, 2014 • Virobay Inc • Pharmaceutical preparations • Delaware
THIS INDEMNITY AGREEMENT (the “Agreement”) is made and entered into as of , 2014, between Virobay, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
VIROBAY, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • July 2nd, 2014 • Virobay Inc • Pharmaceutical preparations • California
THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement’) is entered into as of the 18th day of May, 2010, by and among VIROBAY, INC., a Delaware corporation (the “Company”) and the investors listed on EXHIBIT A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor.”
LEASE AGREEMENTLease Agreement • September 10th, 2014 • Virobay Inc • Pharmaceutical preparations
THIS LEASE AGREEMENT is made this 22 day of March, 2013, between Willow Park Holding Company II, LLC, a Delaware limited liability company (“Landlord”), and the Tenant named below.
ContractAssignment Agreement • October 6th, 2014 • Virobay Inc • Pharmaceutical preparations • California
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • October 6th, 2014 • Virobay Inc • Pharmaceutical preparations • New York
This DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”) is entered into as of January 4, 2012 (the “Effective Date”) by and between VIROBAY INC., a Delaware corporation with its principal place of business at 1490 O’Brien Drive, Suite G, Menlo Park, CA 94025, USA (“Virobay”), and LEO PHARMA A/S, a Danish private limited company with its principal place of business at 55, Industriparken, 2750 Ballerup, Denmark (“LEO”). Virobay and LEO are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
VIROBAY, INC. WARRANT TO PURCHASE PREFERRED STOCKVirobay Inc • July 2nd, 2014 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, TPG BIOTECHNOLOGY PARTNERS II, L.P., or its assigns (the “Holder” or “Purchaser”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from VIROBAY, INC., a Delaware corporation (the “Company”) up to one million one hundred twenty-eight thousand eight hundred eighty-seven (1,128,887) shares of Series A Preferred Stock of the Company (the “Series A Stock”), subject to the vesting provisions set forth herein.
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASSIGNMENT AGREEMENT BY AND BETWEEN VIROBAY,...Assignment Agreement • October 6th, 2014 • Virobay Inc • Pharmaceutical preparations • California
THIS ASSIGNMENT AGREEMENT (the “Agreement”), effective as of June 2, 2006 (“Effective Date”), is by and between Virobay, Inc., a Delaware corporation having its principal place of business at 345 California Street, Suite 2600, San Francisco, CA 94104 (“Virobay”) and APPLERA CORPORATION, a Delaware corporation, by and through the CELERA GENOMICS GROUP having its principal place of business at 45 West Gude Drive, Rockville, Maryland 20850 (“Celera”). Celera and Virobay are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
